## Pathophysiology of Diabetic Nephropathy and GFR Decline **Key Point:** The primary mechanism of GFR decline in diabetic nephropathy is **hemodynamic**: chronic elevation of glomerular capillary hydrostatic pressure (P~GC~) due to preferential efferent arteriolar vasoconstriction mediated by angiotensin II. ### Mechanism of GFR Reduction The net driving pressure for ultrafiltration is given by: $$GFR \propto (P_{GC} - P_{BS} - \pi_{GC})$$ In diabetic nephropathy: 1. **Efferent arteriolar vasoconstriction** (via angiotensin II and endothelin) increases P~GC~ acutely, maintaining GFR initially 2. Over time, **glomerular basement membrane thickening** and **podocyte loss** reduce the ultrafiltration coefficient (K~f~) 3. This structural damage eventually overwhelms the hemodynamic compensation, causing GFR to fall **High-Yield:** The initial phase of diabetic nephropathy shows **hyperfiltration** (elevated GFR) due to afferent vasodilation and efferent vasoconstriction. The later phase shows progressive GFR decline as structural injury accumulates. ### Why ACE Inhibitors / ARBs Work These agents block angiotensin II, causing **preferential afferent arteriolar vasodilation**, which: - Reduces P~GC~ - Decreases proteinuria - Slows GFR decline **Clinical Pearl:** In this patient, the 24-hour urine protein of 2.5 g/day indicates overt diabetic nephropathy (nephrotic range proteinuria). The combination of rising creatinine, proteinuria, and hypertension confirms the hemodynamic-structural injury pattern. ### Renal Clearance Interpretation The 24-hour urine creatinine of 1.2 g/day (normal ~1.0–2.0 g/day) is appropriate for his body weight, validating the creatinine-based GFR estimate. The Cockcroft-Gault GFR of 45 mL/min/1.73 m² places him in **CKD stage 3b**, requiring aggressive blood pressure and glycemic control.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.